Epilepsy device developer NeuroSigma has withdrawn its $50M IPO plans
The Los Angeles-based company developing its drug-resistant epilepsy system has officially backed out of its IPO plans.
Way beyond a watch: Sensor + app + bracelet combo is the future of wearables
Health monitoring devices of the future will not just be biometric tracking devices or journaling apps or detection and alerting systems, but all of the above as part of one comprehensive solution. Designers at Artefact set out to think up a solution that would address the entire experience of living with epilepsy. It’s a complex […]
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Epilepsy meets the crowd with healthcare crowdfunder Poliwogg
New epilepsy treatments plus solutions for certain genetic liver and lung ailments will test the power of crowdfunding. New York’s Poliwogg will announce today at the JP Morgan Healthcare Conference that it has struck partnerships with the Epilepsy Foundation and Alpha 1 Foundation. Both groups will leverage their connections, used primarily for nonprofit grants, to […]